In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they ...

Regeneron has announced new results from the phase 2 COURAGE trial evaluating trevogrumab (anti-GDF8/anti-myostatin) for its ...

Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, ...

Bristol Myers Squibb (BMS) has announced new retrospective analyses on serologic responses and clinical outcomes with COVID-19 vaccination in participants treated with Zeposia (ozanimod) from the ...

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment ...

Logistical challenges are not new in clinical research, from the high cost of developing new therapies to complexities in ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square ...

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the ...

Chiesi UK and Ireland has announced a new programme to help transform COPD diagnosis across the UK by providing NHS primary ...

Why industry needs to engage earlier, explain value more clearly, understand service pressures and take shared responsibility ...

The results for litifilimab support the potential to achieve rapid and durable improvements in skin disease activity ...

The annual awards recognise excellence across 15 categories spanning innovation, manufacturing, sustainability and leadership ...